Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Rituximab for intraocular lymphoma.

Literature DB >> 19202422

Rituximab for intraocular lymphoma.

Sujit Itty, Jose S Pulido.

Abstract

Entities: Chemical Disease

Mesh：

Substances：

Year: 2009 PMID： 19202422 DOI： 10.1097/IAE.0b013e318192f574

Source DB: PubMed Journal: Retina ISSN： 0275-004X Impact factor: 4.256

Keyword Cloud
Cited

× No keyword cloud information.

23 in total

Review 1. Primary vitreoretinal lymphoma: a report from an International Primary Central Nervous System Lymphoma Collaborative Group symposium.

Authors: Chi-Chao Chan; James L Rubenstein; Sarah E Coupland; Janet L Davis; J William Harbour; Patrick B Johnston; Nathalie Cassoux; Valerie Touitou; Justine R Smith; Tracy T Batchelor; Jose S Pulido
Journal: Oncologist Date: 2011-11-01

2. Long-term daclizumab therapy for the treatment of noninfectious ocular inflammatory disease.

Authors: Keith Wroblewski; H Nida Sen; Steven Yeh; Lisa Faia; Zhuging Li; Pushpa Sran; Sapna Gangaputra; Susan Vitale; Patti Sherry; Robert Nussenblatt
Journal: Can J Ophthalmol Date: 2011-07-07 Impact factor: 1.882

Review 3. Biology and treatment of primary central nervous system lymphoma.

Authors: Alain P Algazi; Cigall Kadoch; James L Rubenstein
Journal: Neurotherapeutics Date: 2009-07 Impact factor: 7.620

4. Regression of refractory intraocular large B-cell lymphoma with lenalidomide monotherapy.

Authors: James L Rubenstein; Patrick A Treseler; Paul J Stewart
Journal: J Clin Oncol Date: 2011-04-25 Impact factor: 44.544

Review 5. New approaches in primary central nervous system lymphoma.

Authors: Eleanor Fraser; Katherine Gruenberg; James L Rubenstein
Journal: Chin Clin Oncol Date: 2015-03

6. Primary Intraocular Diffuse Large B-cell Lymphoma: Diagnostic Difficulties in Deep Retinal Infiltrations with Vitritis.

Authors: Katarzyna Kapelko-Slowik; Donata Urbaniak-Kujda; Anna Turno-Krecicka; Stanislaw Potoczek; Jaroslaw Dybko; Monika Biernat; Miroslaw Slowik
Journal: Indian J Hematol Blood Transfus Date: 2015-09-20 Impact factor: 0.900

Rituximab for intraocular lymphoma.

Review 1. Primary vitreoretinal lymphoma: a report from an International Primary Central Nervous System Lymphoma Collaborative Group symposium.

2. Long-term daclizumab therapy for the treatment of noninfectious ocular inflammatory disease.

Review 3. Biology and treatment of primary central nervous system lymphoma.

4. Regression of refractory intraocular large B-cell lymphoma with lenalidomide monotherapy.

Review 5. New approaches in primary central nervous system lymphoma.

6. Primary Intraocular Diffuse Large B-cell Lymphoma: Diagnostic Difficulties in Deep Retinal Infiltrations with Vitritis.

Review 7. The Challenge of Primary Central Nervous System Lymphoma.

8. Efficacy and Complications of Intravitreal Rituximab Injection for Treating Primary Vitreoretinal Lymphoma.

9. The future of primary intraocular lymphoma (retinal lymphoma).

10. How I treat CNS lymphomas.